-
Symbol
-
IMDX on Nasdaq
-
Investment type
-
Equity / Common Stock, no par value
-
Latest Disclosed Shares Owned
-
12,082,089 shares
-
Security Ownership %
-
37%
Neal C. Bradsher ownership in Insight Molecular Diagnostics Inc. Common Stock, no par value (IMDX)
12 Feb 2026 - Neal C. Bradsher has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,082,089 shares of Insight Molecular Diagnostics Inc. Common Stock, no par value (IMDX).
This represents 37% ownership of the company.
In their previous filing dated 10 Feb 2025, BROADWOOD PARTNERS, L.P. had reported owning 11,560,350 shares, indicating an increase of +4.5%.
.